PFBT
EGRX

Parkside Financial Bank & Trust’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-69
Closed -$1.96K – 2114
2023
Q1 		$1.96K Hold
69
– – ﹤0.01% 1706
2022
Q4 		$2.02K Hold
69
– – ﹤0.01% 1682
2022
Q3 		$2K Sell
69
-12
-15% -$440 ﹤0.01% 1615
2022
Q2 		$4K Buy
81
+51
+170% +$2.34K ﹤0.01% 1388
2022
Q1 		$1K Sell
30
-33
-52% -$1.58K ﹤0.01% 1804
2021
Q4 		$3K Hold
63
– – ﹤0.01% 1547
2021
Q3 		$4K Buy
63
+60
+2,000% +$2.95K ﹤0.01% 1383
2021
Q2 		$0 Sell
3
-43
-93% -$1.77K ﹤0.01% 1826
2021
Q1 		$2K Hold
46
– – ﹤0.01% 1547
2020
Q4 		$2K Buy
46
+23
+100% +$1.08K ﹤0.01% 1470
2020
Q3 		$1K Buy
+23
New +$1.01K ﹤0.01% 1460
2020
Q2 		– Sell
-9
Closed – – 1734
2020
Q1 		$0 Sell
9
-4
-31% -$201 ﹤0.01% 1695
2019
Q4 		$1K Hold
13
– – ﹤0.01% 1512
2019
Q3 		$1K Hold
13
– – ﹤0.01% 1487
2019
Q2 		$1K Hold
13
– – ﹤0.01% 1501
2019
Q1 		$1K Buy
13
+1
+8% +$44 ﹤0.01% 1460
2018
Q4 		$0 Buy
12
+4
+50% +$206 ﹤0.01% 1602
2018
Q3 		$1K Hold
8
– – ﹤0.01% 1414
2018
Q2 		$1K Buy
8
+3
+60% +$189 ﹤0.01% 1410
2018
Q1 		$0 Hold
5
– – ﹤0.01% 1561
2017
Q4 		$0 Hold
5
– – ﹤0.01% 1521
2017
Q3 		$0 Buy
5
+1
+25% +$60 ﹤0.01% 1557
2017
Q2 		$0 Hold
4
– – ﹤0.01% 1572
2017
Q1 		$0 Hold
4
– – ﹤0.01% 1542
2016
Q4 		$0 Buy
+4
New +$291 ﹤0.01% 1510

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Parkside Financial Bank & Trust's EGRX Position: Q2 2023 in Review

Parkside Financial Bank & Trust sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2023, closing a stake of 69 shares — an estimated $1.96K sold.

Parkside Financial Bank & Trust first reported a position in EGRX in Q4 2016 and held it in 25 quarters. The position peaked at $4K in Q2 2022. 126 funds tracked by Wall St. Rank hold EGRX as of Q2 2023.

  • Parkside Financial Bank & Trust reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 69 Eagle Pharmaceuticals, Inc. shares in Q2 2023, an estimated $1.96K.
  • Parkside Financial Bank & Trust first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2016 and held it in 25 quarters.
  • Parkside Financial Bank & Trust's Eagle Pharmaceuticals, Inc. position peaked at $4K in Q2 2022.
  • 126 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2023.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2023, filed 15 Aug 2023.